Pictorial Warning Labels and Memory for Cigarette Health-risk Information Over Time

December 12, 2017 updated by: Ellen Peters, Ohio State University
Pictorial cigarette warning labels (PWLs) are thought to increase risk knowledge, but experimental research has not examined PWLs' longer term effects on memory for health risks. This trial tests memory for health risks immediately or after a six-week delay for US-representative adult smokers, US-representative teen smokers/vulnerable smokers, and Appalachian-representative adult smokers. In addition, the trial tests the effects of different warning label components and the consequences of memory for labels on risk perceptions and quit intentions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

4424

Phase

  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 19-65 years old (adult samples)
  • have smoked 100+ lifetime cigarettes (adult samples)
  • currently smoke "every day" or "some days." (adult samples)
  • 14-18 years old (teen sample)
  • have ever smoked a cigarette (teen sample)

Exclusion Criteria:

• have not ever smoked a cigarette (all samples)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Text-only PWL, immediate post

Exposure to 9 FDA-mandated warning labels

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

Control condition
Experimental: Text-only PWL, delay posttest

Exposure to 9 FDA-mandated warning labels

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels

Control condition
Experimental: Low-emot PWL, immediate posttest

Exposure to 9 warning labels paired with image that elicited little emotion

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

Pictorial warning
Experimental: Low-emot PWL, delay posttest

Exposure to 9 warning labels paired with image that elicited little emotion

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels

Pictorial warning
Experimental: High-emot PWL, immediate posttest

Exposure to 9 warning labels paired with image that elicited high emotion

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered immediately following last exposure to warning labels

Pictorial warning
Experimental: High-emot PWL, delay posttest

Exposure to 9 warning labels paired with image that elicited high emotion

Posttest measures (e.g., memory, risk perceptions, quit intentions) administered 6 weeks after last exposure to warning labels

Pictorial warning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
graphic warning label recall
Time Frame: immediately following last exposure or after 6-week delay
free recall for risk information presented in labels (9 text boxes, 1 for each label; coded for exact or equivalent words)
immediately following last exposure or after 6-week delay
smoking risk recognition
Time Frame: immediately following last exposure or after 6-week delay
Participants were subsequently shown twenty-six negative health effects and asked "Which of the following health effects were mentioned in the warnings we showed you?" and responded "Yes, I saw this health effect" or "No, I did not see this health effect." Fourteen risks were mentioned in the warnings (e.g., cancer, harms children, emphysema); six were risks of smoking not presented in the warnings (e.g., wrinkles, diabetes), and six were not risks of smoking (e.g., acne, thyroid problems).
immediately following last exposure or after 6-week delay

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
smoking risk perceptions
Time Frame: immediately following last exposure or after 6-week delay
participants completed several scale items about how much risk they perceived smoking posed to them (e.g., "Compared to the average nonsmoker your age, gender, and race, how would you rate your chances of": 1) "getting a life threatening illness because of smoking," 2) "getting lung cancer," and 3) "dying at a younger age than average" (-3 = Much lower, +3 = Much higher))
immediately following last exposure or after 6-week delay
quit intentions
Time Frame: immediately following last exposure or after 6-week delay
participants' intentions to quit smoking
immediately following last exposure or after 6-week delay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2015

Primary Completion (Actual)

January 27, 2016

Study Completion (Actual)

January 27, 2016

Study Registration Dates

First Submitted

December 8, 2017

First Submitted That Met QC Criteria

December 12, 2017

First Posted (Actual)

December 18, 2017

Study Record Updates

Last Update Posted (Actual)

December 18, 2017

Last Update Submitted That Met QC Criteria

December 12, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • P50CA180908A1
  • P50CA180908 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Text-only PWL

3
Subscribe